Will Hexo’s Direct Offering Help Push the Stock Higher?
Hexo shares slid on Friday after the Canadian cannabis firm announced that it is conducting a direct offering of $20 million worth of shares.
All Work
Chris Lange
What’s Next for Durect After FDA Posimir Vote
Durect shares dropped early on Friday after an FDA committee vote on Posimir, the company’s pain relief treatment.
Does CSX Deserve More Credit for Its Q4 Earnings Beat?
CSX shares fell after it released mixed fourth-quarter financial results after the markets closed on Thursday.
Can Nike Outrun a Ban on Its Latest Shoes?
Nike has made great strides over the past year, not only with its shares up incredibly but also its new Vaporfly Next% shoes have dominated the running scene.
Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?
Neon Therapeutics shares shot up on Thursday after the firm announced that it will be acquired by BioNTech. Are Neon Therapeutics shareholders getting enough out of the deal?
Is This the Quarter Schlumberger Turns It Around?
Schlumberger is scheduled to release its fourth-quarter financial results before the markets open on Friday.
How Morgan Stanley Won Big in Q4
Morgan Stanley stock rose after it released better than expected fourth-quarter financial results early Thursday.
Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.
Does FDA Decision Mean a Bright Future for This Flu Vaccine?
An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.
Will Trading Revenues Play a Big Role in Morgan Stanley’s Q4 Report?
Morgan Stanley is set to release its most recent quarterly numbers before the opening bell on Thursday. How big a role will trading revenue play in the results?
Is It Time to Take Profits on Bank of America After Earnings?
Bank of America reported mixed fourth-quarter financial results before the markets opened on Wednesday. Is it time to take profits?
Does UnitedHealth Deserve More Credit for Q4?
When UnitedHealth reported mixed fourth-quarter financial results before the markets opened on Wednesday.
Is Goldman Sachs Poised for a Big Win?
Goldman Sachs is set to report its most recent quarterly results before the markets open on Wednesday.
Will 2020 Be the Breakout Year for Amazon?
Although Amazon.com stock has not kept pace with markets over the past year, a couple analysts are calling for shares to run much higher.
Will UnitedHealth Lift the Dow Again When It Reports Wednesday?
UnitedHealth is scheduled to report its most recent quarterly results before the opening bell on Wednesday.
What to Expect When Bank of America Reports Wednesday
Bank of America is scheduled to release its fourth-quarter financial results before the markets open on Wednesday.
Investment Banking Boosts Citigroup
Citigroup released better than expected fourth-quarter financial results before the markets opened on Tuesday, buoyed by strong investment banking results.
Wells Fargo Burned Again by Past Misdeeds
Wells Fargo released a disappointing fourth-quarter earnings report before the opening bell on Tuesday, made worse by litigation accruals.
Why Aquestive Therapeutics’ Seizure Treatment May Get Butted Out
Aquestive Therapeutics' shares lost nearly a third on Monday after the firm received an update from the FDA concerning its seizure treatment.
Are Five Below Holiday Sales Signaling a New Trend in Retail?
Five Below joins the list of retailers that posted underwhelming holiday sales, and its shares were crushed on Monday.